SynBio
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Synbio may refer to: *Synthetic Biology, an area of biological research that combines science and engineering. *SynBio, a biological research project based in Russia, which is developing treatments against types of cancer and other diseases.
SynBio is a long-term project started in 2011 with the goal of creating innovative medicines, including what are known as Biobetters. This project is a collaborative effort of several Russian and international pharmaceutical companies. The largest private participant of SynBio is the Human Stem Cells Institute (HSCI), a leading Russian biotech company, and Rusnano is a key investor.
The project is a significant example of international cooperation between researchers in Russia, England, and Germany. Special project company SynBio LLC is headquartered in Moscow.
Currently, SynBio LLC is developing nine drugs based on three biotechnology platforms (Histone, PolyXen and Gemacell) for the treatment of liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes mellitus. The SynBio project also entails the creation of modern production facilities.
These facilities will be dedicated to the manufacturing of the company's pharmaceutical substances and market-ready medicines once they have successfully undergone clinical testing.
Text derived from https://en.wikipedia.org/w/index.php?oldid=672872602 under CC BY-SA 4.0; modifications have been made.